Abstract-In high-Na ϩ , low-K ϩ diets, which suppress renin release in salt-sensitive groups, the mechanisms maintaining increases in renin-angiotensin-aldosterone system activation downstream from renin and renin-angiotensin-aldosterone system-induced effects on blood pressure (BP) are uncertain. Whether circulating angiotensinogen concentrations (AGT) or its determinants may contribute to maintaining serum aldosterone concentrations (aldosterone) and increases in BP on high-Na ϩ , low-K ϩ diets was evaluated in 579 participants of a community sample of African ancestry. Plasma renin concentrations were inversely related to BP (PϽ0.0001) and an index of salt intake (24-hour urinary Na ϩ /K ϩ , PϽ0.0001). An interaction between AGT and urinary Na ϩ /K ϩ was independently associated with aldosterone (PϽ0.001) and systolic BP (SBP; PϽ0.05). Independent of confounders, in participants with urinary Na ϩ /K ϩ at or more than the median for the sample, AGT was positively associated with aldosterone (PϽ0.0001) and SBP (PϽ0.005). No independent AGT-aldosterone or AGT-SBP relationships were noted in participants with urinary Na ϩ /K ϩ less than the median for the sample. Standardized ␤-coefficients (slopes) of AGT-aldosterone and AGT-SBP relationships were greater in participants with urinary Na ϩ /K ϩ at or more than the median (AGT-aldosteroneϭ0.30Ϯ0.06, AGT-SBPϭ0.16Ϯ0.05) compared with those with urinary Na ϩ /K ϩ less than the median (AGT-aldosteroneϭϪ0.04Ϯ0.06; AGT-SBPϭϪ0.03Ϯ0.05; PϽ0.01-0.0001 for comparison of slopes). The AGT-SBP relationship in participants with urinary Na ϩ /K ϩ at or more than the median for the sample was equivalent to the relationship between body mass index and BP. In conclusion, in participants of African ancestry, in the presence of high-Na ϩ , low-K ϩ diets, which suppress renin release, renin-angiotensin-aldosterone system activation and its impact on BP are maintained in part by AGT. (Hypertension. 2012;59:62-69.) • Online Data Supplement Key Words: renin-angiotensin-aldosterone system Ⅲ salt intake Ⅲ angiotensinogen D espite the well-recognized role of the renin-angiotensinaldosterone system (RAAS) in blood pressure (BP) control, high-sodium (Na ϩ ), low-potassium (K ϩ ) diets in salt-sensitive populations suppress renin release. [1] [2] [3] [4] Consequently, RAAS blockers may not produce beneficial effects on BP in salt-sensitive populations, such as those of African ancestry, 5, 6 and despite the benefits that may accrue from RAAS blockers, 7-9 they are not recommended as first-line therapy in these groups. 10, 11 Nonetheless, despite a low renin state, populations of African ancestry tend to have a disproportionately high prevalence of end-organ damage, 12, 13 and in previous studies conducted in groups of African ancestry, a somewhat perplexing dissociation exists between a low renin status and relatively higher aldosterone concentrations. 14 Indeed, in low renin states in salt-sensitive individuals, reductions in plasma aldosterone concentrations may be less than those predicted from the extent of renin suppression. [1] [2] [3] [4] Moreover, attenuated decreases in plasma aldosterone concentrations are essential for dietary salt-related increases in BP, 15 and the effect of aldosterone on BP in groups of African ancestry may be more pronounced in the presence of high-Na ϩ , low-K ϩ diets. 16, 17 Although an increased adrenal sensitivity to angiotensin II may occur in salt-sensitive hypertension, 1,2,4 the factors that maintain increases in downstream circulating RAAS concentrations despite suppression of plasma renin release in the Because circulating angiotensinogen concentrations may approximate the Michaelis-Menten constant for renin, cleavage of angiotensinogen into angiotensin I is thought to be a rate-limiting step in RAAS activation. 18 It is, therefore, possible that, in the presence of high-Na ϩ , low-K ϩ diets, increases in circulating angiotensinogen concentrations may maintain RAAS activation despite suppression of plasma renin release. In this way angiotensinogen and, hence, the RAAS may contribute to BP responses to salt intake. Indeed, some 19 -22 but not other 23 studies suggest that genetic variation of the angiotensinogen gene is associated with reductions in BP in response to decreases in Na ϩ intake, 19 to relationships between Na ϩ intake and BP, 20, 21 and to BP in the presence of a high Na ϩ intake. 22 However, few studies have reported on the relationship between angiotensinogen or its genotype and the extent of downstream RAAS activation. In this regard, although the angiotensinogen genotype may be associated with circulating aldosterone concentrations, 24 no relationship between circulating angiotensinogen concentrations and plasma aldosterone concentrations has been noted. 25 Nevertheless, these studies 24, 25 were conducted in children 25 and in cohorts of small study samples. 24, 25 Moreover, in neither of these studies 24, 25 was the relationship between angiotensinogen and RAAS activation assessed in the context of salt intake or an independent relationship between angiotensinogen or its genotype and BP observed. 24, 25 In the present study we, therefore, evaluated in a relatively large study sample of a group of black African ancestry the hypothesis that circulating angiotensinogen concentrations are associated with activation of the RAAS downstream from renin (as indexed by circulating aldosterone concentrations) and with an increased BP in the context of a high-Na ϩ , low-K ϩ diet.
D
espite the well-recognized role of the renin-angiotensinaldosterone system (RAAS) in blood pressure (BP) control, high-sodium (Na ϩ ), low-potassium (K ϩ ) diets in salt-sensitive populations suppress renin release. [1] [2] [3] [4] Consequently, RAAS blockers may not produce beneficial effects on BP in salt-sensitive populations, such as those of African ancestry, 5, 6 and despite the benefits that may accrue from RAAS blockers, 7-9 they are not recommended as first-line therapy in these groups. 10, 11 Nonetheless, despite a low renin state, populations of African ancestry tend to have a disproportionately high prevalence of end-organ damage, 12, 13 and in previous studies conducted in groups of African ancestry, a somewhat perplexing dissociation exists between a low renin status and relatively higher aldosterone concentrations. 14 Indeed, in low renin states in salt-sensitive individuals, reductions in plasma aldosterone concentrations may be less than those predicted from the extent of renin suppression. [1] [2] [3] [4] Moreover, attenuated decreases in plasma aldosterone concentrations are essential for dietary salt-related increases in BP, 15 and the effect of aldosterone on BP in groups of African ancestry may be more pronounced in the presence of high-Na ϩ , low-K ϩ diets. 16, 17 Although an increased adrenal sensitivity to angiotensin II may occur in salt-sensitive hypertension, 1, 2, 4 the factors that maintain increases in downstream circulating RAAS concentrations despite suppression of plasma renin release in the presence of high-Na ϩ , low-K ϩ diets in salt-sensitive populations, such as those of African ancestry, are still uncertain.
Because circulating angiotensinogen concentrations may approximate the Michaelis-Menten constant for renin, cleavage of angiotensinogen into angiotensin I is thought to be a rate-limiting step in RAAS activation. 18 It is, therefore, possible that, in the presence of high-Na ϩ , low-K ϩ diets, increases in circulating angiotensinogen concentrations may maintain RAAS activation despite suppression of plasma renin release. In this way angiotensinogen and, hence, the RAAS may contribute to BP responses to salt intake. Indeed, some 19 -22 but not other 23 studies suggest that genetic variation of the angiotensinogen gene is associated with reductions in BP in response to decreases in Na ϩ intake, 19 to relationships between Na ϩ intake and BP, 20, 21 and to BP in the presence of a high Na ϩ intake. 22 However, few studies have reported on the relationship between angiotensinogen or its genotype and the extent of downstream RAAS activation. In this regard, although the angiotensinogen genotype may be associated with circulating aldosterone concentrations, 24 no relationship between circulating angiotensinogen concentrations and plasma aldosterone concentrations has been noted. 25 Nevertheless, these studies 24, 25 were conducted in children 25 and in cohorts of small study samples. 24, 25 Moreover, in neither of these studies 24, 25 was the relationship between angiotensinogen and RAAS activation assessed in the context of salt intake or an independent relationship between angiotensinogen or its genotype and BP observed. 24, 25 In the present study we, therefore, evaluated in a relatively large study sample of a group of black African ancestry the hypothesis that circulating angiotensinogen concentrations are associated with activation of the RAAS downstream from renin (as indexed by circulating aldosterone concentrations) and with an increased BP in the context of a high-Na ϩ , low-K ϩ diet.
Methods

Study Group
The University of the Witwatersrand Committee for Research on Human Subjects approved the protocol (approval No. M02-04-72 and renewed as M07-04-69). Participants gave informed, written consent. The study design has been described recently. 26 -29 Participants were from randomly recruited black-African nuclear families with siblings Ͼ16 years of age from the South West Township of Johannesburg. Of the 754 participants sampled in a substudy, 579 had 24-hour urine samples that met with prespecified quality control criteria described previously. 26 
Clinical, Demographic, and Anthropometric Measurements
A standardized questionnaire was administered to obtain demographic and clinical data. 26 -29 Nurse-derived conventional BP was measured using a mercury sphygmomanometer after 10 minutes of rest in the seated position as described previously 28 20 to 30 minutes after obtaining blood samples in the opposite arm to that subjected to venesection. Five consecutive BP readings were obtained using an appropriately sized cuff, 30 to 60 seconds apart. The average of the 5 readings was taken as the BP. Only 0.17% of visits had fewer than the planned BP recordings. 26 -29 Diabetes mellitus or abnormal blood glucose control was defined as the use of insulin or oral hypoglycemic agents or a hemoglobin A1C Ͼ6.1%. 30 In women, menopausal status was confirmed with measures of follicle stimulating hormone.
Urinary Electrolyte Excretion Rates and Creatinine Clearance
Timed urine samples were obtained over a 24-hour period after discarding urine obtained immediately before the start of the collection period. The mean (ϮSD) time period of urine collection was 24.5Ϯ1.4 hours (range: 24.0 -31.1 hour). Urine Na ϩ , K ϩ , and creatinine concentrations were measured and 24-hour urine Na ϩ and K ϩ excretion rates calculated from the product of 24-hour urine volumes and urine electrolyte concentrations. The quality of urine sample collection was determined as described previously. 26 Creatinine clearance was determined from the following formula: (urinary creatinine concentrationϫvolume)/plasma creatinine concentration.
Renin, Aldosterone, Angiotensinogen, and C-Reactive Protein Concentrations
Blood samples were obtained in the supine position after 10 minutes of rest in the morning between 10:00 AM and 12:00 PM. Participants were allowed to continue taking all routine medications at the time. However, sensitivity analysis was conducted in participants not receiving RAAS blockers (nϭ546; see data analysis), and for relationships with serum aldosterone, only participants not receiving thiazide diuretic agents were analyzed (nϭ453). After centrifugation, samples were stored at Ϫ70°C until the time of analysis. Plasma renin, serum aldosterone, plasma angiotensinogen, and serum C-reactive protein concentrations were measured as described in the expanded Methods section (available in the online Data Supplement; please see http://hyper.ahajournals.org).
Angiotensinogen Genotyping
DNA was extracted from whole blood by lysing red blood cells and digesting the remaining white cell pellet with proteinase K. Genotyping of the A3 C transition at nucleotide Ϫ20 and the G3 A substitution at position Ϫ217 of the 5Ј upstream promoter region of the AGT gene was undertaken using PCR restriction fragment length polymorphism-based techniques using the appropriate primer pairs and restriction enzymes, as described previously. 31 
Data Analysis
For database management and statistical analysis, SAS software, version 9.1 (SAS Institute Inc, Cary, NC), was used. Data are shown as meanϮSD unless otherwise specified. Because circulating renin, aldosterone, angiotensinogen, and C-reactive protein (CRP) concentrations were not normally distributed, in data analysis they were expressed as log renin, log CRP, square-root aldosterone, and square-root angiotensinogen values. Relationships with serum aldosterone concentrations and BP were determined from multivariate regression models with age, sex, BMI, the presence of diabetes mellitus/abnormal blood glucose control, regular alcohol consumption, regular tobacco use, creatinine clearance, and antihypertensive treatment (in all participants) included in the regression models. Multivariate regression models including the same confounders were used to determine the significance of interactive terms independent of the individual terms. The P values derived from multivariate models were adjusted for nonindependence of family members using a mixed model of analysis, as defined by SAS software. Because RAAS blockers and diuretics may modify plasma renin and aldosterone concentrations and relationships between angiotensinogen concentrations and aldosterone concentrations or BP, sensitivity analysis was conducted where the aforementioned relationships were as-sessed in participants not receiving RAAS blockers and diuretics. In further sensitivity analysis, 2.2% of participants were excluded from the analysis because they had an aldosterone:renin ratio that exceeded a previously defined threshold of 5.4 ng/dL per nanogram per liter, which is suggestive of primary aldosteronism. 32 Table 1 gives the clinical, demographic, and hemodynamic characteristics of the study participants and of the participants with a urinary Na ϩ /K ϩ at or more than or less than the median for the sample. Medication taken by participants is described in the online Data Supplement. As compared with participants with a urinary Na ϩ /K ϩ less than the median for the sample, participants with a urinary Na ϩ /K ϩ at or more than the median for the sample were younger and less overweight/obese, and a lower proportion had diabetes mellitus or an hemoglobin A1C Ͼ6.1% (Table 1) . Although no differences in unadjusted BP were noted between the groups, multivariate-adjusted systolic BP was greater in the group with a urinary Na ϩ /K ϩ at or more than the median (132Ϯ17 versus 129Ϯ17 mm Hg; PϽ0.05). As compared with the group studied, those without appropriate 24-hour urine collections who were excluded from the study sample (nϭ185) Figure S1 .
Results
Characteristics of the Participants
RAAS Profiles
With multivariate adjustments, as compared with participants with a urinary Na ϩ /K ϩ less than the median for the sample, participants with a urinary Na ϩ /K ϩ at or more than the median for the sample had lower serum aldosterone and square-root serum aldosterone concentrations and lower log plasma renin concentrations (Table 2) . However, angiotensinogen concentrations were similar between the 2 groups ( Table 2) . 
Relationships Between Urinary Na
Relationships With Plasma Renin Concentrations
In keeping with a marked degree of salt sensitivity of the study group, striking negative bivariate relationships were noted between log plasma renin concentrations and both systolic BP (rϭϪ0.18; PϽ0.0001) and urinary Na ϩ /K 
Independent Relationship Between Circulating Angiotensinogen and Aldosterone Concentrations
In a multivariate model, plasma angiotensinogen concentrations, plasma renin concentrations, male sex, and diuretic use were positively associated with the square root of serum aldosterone concentrations (Table 3 ). In contrast, urinary Na ϩ /K ϩ was negatively associated with the square root of serum aldosterone concentrations (Table 3 ). In analysis conducted in participants not receiving RAAS blockers or diuretics or after excluding participants with an aldosterone:renin ratio suggestive of primary aldosteronism, similar outcomes were noted (please see Table S1 ).
Relationship Between Circulating Angiotensinogen and Aldosterone Concentrations Depends on Salt Intake
Independent of confounders and the individual terms, a strong interaction between plasma angiotensinogen concentrations and urinary Na ϩ /K ϩ was associated with serum aldosterone concentrations (PϽ0.001). This translated into a positive relationship between plasma angiotensinogen concentrations and serum aldosterone concentrations in participants with a urinary Na ϩ /K ϩ at or more than the median for the sample but not in participants with a urinary Na ϩ /K ϩ less than the median for the sample (Table 4) , as well as incremental increases in the multivariate-adjusted relationships between plasma angiotensinogen concentrations and serum aldosterone concentrations across tertiles of urinary Na ϩ /K ϩ (please see Figure S2 ). The relationship between plasma angiotensinogen and serum aldosterone concentrations was greater in participants with a urinary Na ϩ /K ϩ at or more than as compared with less than the median for the sample (Table 4) . This also translated into a greater slope (␤-coefficient) of the relationship between plasma angiotensinogen concentrations and serum aldosterone concentrations in participants with a urinary Na ϩ /K ϩ at or more than as compared with less than the median for the sample (Figure, left) and a greater slope (␤-coefficient) of the relationship between plasma angiotensinogen concentrations and serum aldosterone concentrations in participants in the third as compared with the first and second tertiles of urinary Na ϩ /K ϩ (please see Figure S2 ). The standardized slope of the relationship between plasma angiotensinogen concentrations and serum aldosterone concentrations in those with urinary Na ϩ /K ϩ at or more than the median (0.299Ϯ0.056) was greater than the standardized slope of the relationship between plasma renin concentrations and serum aldosterone concentrations (0.132Ϯ0.040; PϽ0.05). The same factors were included in both models. Additional factors included in the regression analysis were treatment for hypertension, diabetes mellitus, or a glycated hemoglobin Ͼ6.1%, square-root creatinine clearance, and regular tobacco use. P values are further adjusted for nonindependence of family members. Median urinary Na ϩ /K ϩ is 3.714. *PϽ0.005 vs relationship in group with urinary Na ϩ /K ϩ less than the median.
In analysis conducted in participants not receiving RAAS blockers or diuretics or after excluding participants with an aldosterone:renin ratio suggestive of primary aldosteronism, similar results were noted (please see Table S2 ).
Relationship Between Circulating Angiotensinogen and BP Depends on Salt Intake
In multivariate models, plasma angiotensinogen concentrations were not independently associated with systolic (Pϭ0.064) or diastolic (Pϭ0.09) BP. However, in the whole group, independent of confounders and the individual terms, an interaction between plasma angiotensinogen concentrations and urinary Na ϩ /K ϩ was associated with systolic BP (PϽ0.05) but not with diastolic BP. This translated into a positive relationship between square-root plasma angiotensinogen concentrations and systolic BP (Table 4) and an incremental increase in the angiotensinogen-systolic BP relationship across increasing tertiles (please see Figure S2 ) in participants with a urinary Na ϩ /K ϩ at or more than the median for the sample but not in participants with a urinary Na ϩ /K ϩ less than the median for the sample. This also translated into a greater slope (␤-coefficient) of the relationship between plasma angiotensinogen concentrations and systolic BP (Figure) and an incremental increase in the slope of the angiotensinogen-systolic BP relationship across increasing tertiles (please see Figure S2 ) in participants with a urinary Na ϩ /K ϩ at or more than as compared with less than the median for the sample. As a consequence, every 1-SD (1.08) increase in plasma angiotensinogen concentrations translated into a 3.21Ϯ0.9-mm Hg increase in systolic BP in participants with a urinary Na ϩ /K ϩ at or more than the median for the sample, as compared with a 0.63Ϯ1.12-mm Hg decrease in systolic BP in participants with a urinary Na ϩ /K ϩ less than the median for the sample (PϽ0.01). In analysis conducted in participants not receiving RAAS blockers or diuretics or after excluding participants with an aldosterone:renin ratio suggestive of primary aldosteronism, similar outcomes were noted (please see Table S3 ).
Factors Related to Circulating Angiotensinogen Concentrations and Their Impact on Variations in Aldosterone Concentrations and BP
In multivariate analysis, the A3 C transition at nucleotide Ϫ20 of the AGT gene and log CRP concentrations but not the G3 A substitution at position Ϫ217 of the AGT gene were independently related to circulating angiotensinogen concentrations (Table 5 ). However, neither AGT genotype nor log CRP concentrations were independently related to serum aldosterone concentrations or BP. Moreover, neither AGT genotype (Ϫ20A3 C, Pϭ0.78; Ϫ217G3 A, Pϭ1.00) nor log CRP concentrations (Pϭ0.72) were independently related to serum aldosterone concentrations in participants with a urinary Na ϩ /K ϩ at or more than the median for the sample. Similarly, neither AGT genotype (Ϫ20A3 C, Pϭ0.30; Ϫ217G3 A, Pϭ0.58) nor log CRP concentrations (Pϭ0.34) were independently related to systolic BP in participants with a urinary Na ϩ /K ϩ at or more than the median for the sample.
Discussion
The main findings of the present study are that, in the context of a high-Na ϩ and low-K ϩ diet (indexed by urinary Na ϩ /K ϩ ), which suppresses renin release (resulting in a negative relationship between renin and BP), angiotensinogen is an important determinant of RAAS activation (as indexed by aldosterone concentrations) and of systolic BP. Some previous studies have suggested that the AGT genotype is associated with reductions in BP in response to decreases in Na ϩ intake 19 ; to relationships between Na ϩ intake and BP 20, 21 ; and to BP in participants with a high Na ϩ intake, 22 findings that have not been confirmed by all studies. 23 Although an impact of circulating angiotensinogen concentrations was not reported, 16 -18 these studies nevertheless suggest that angiotensinogen may play an important role in contributing to RAAS activation and BP in salt-sensitive individuals on a high Na ϩ diet, where renin concentrations are suppressed. However, in none of these studies 19 -21 was a relationship between AGT genotype or angiotensinogen concentrations and RAAS activation downstream from renin demonstrated in participants on a high Na ϩ diet. Moreover, the inability to reproduce relationships between AGT genotype and the effect of Na diets on BP in all of the studies 23 characterizes often inconsistent genetic associations with BP. Thus, measurements of intermediate phenotypes (circulating angiotensinogen concentrations) may be more reliable. Indeed, in this regard the present study is the first to show that circulating angiotensinogen is associated with downstream activation of the RAAS (as indexed by increases in circulating aldosterone concentrations) and with systolic BP in participants receiving a high Na ϩ /low K ϩ diet, despite a negative relationship between renin and salt intake or BP. Therefore, the present study provides evidence to support the notion that RAAS activation through angiotensinogen is a key element in maintaining increases in BP in salt-sensitive groups on high Na ϩ /low K ϩ diets. The multivariate-adjusted relationship between circulating angiotensinogen concentrations and serum aldosterone concentrations or systolic BP in participants with a urinary Na ϩ /K ϩ (index of salt intake) above but not below the median for the sample or in higher as compared with lower tertiles of urinary Na ϩ /K ϩ may in part explain discrepancies that exist in the current literature regarding relationships between circulating angiotensinogen concentrations and aldosterone or BP. Although, in bivariate analysis, angiotensinogen concentrations have been shown to be strongly related to BP in some studies, 25, 33 these relationships are abolished by adjustments for confounders. 25 However, in no previous study has the relationship between angiotensinogen and BP been shown to occur through an interaction with urinary Na ϩ /K ϩ (an index of salt intake). In this regard, the present study provides evidence to indicate that angiotensinogen is associated with systolic BP in participants with a high but not a low urinary Na ϩ /K ϩ or in the highest but not in the lowest tertile of urinary Na ϩ /K ϩ . Furthermore, although angiotensinogen concentrations have been shown previously to be unrelated to circulating aldosterone concentrations in children, 25 in the present study we show that a strong relationship between circulating angiotensinogen and aldosterone concentrations occurs in an adult community sample of participants with a high but not a low urinary Na ϩ /K ϩ . Thus, the role of angiotensinogen in RAAS activation and increases in BP appears to occur during a high Na ϩ and low K ϩ diet when suppression of renin occurs, as opposed to during a low Na ϩ and high K ϩ diet when renin release is stimulated.
Potential explanations for the association of an interaction between circulating angiotensinogen concentrations and salt intake with serum aldosterone concentrations require consideration. Although the actions (and, hence, concentrations) of renin have been thought previously to be the major ratelimiting step in the activation of the RAAS, circulating angiotensinogen concentrations may approximate the Michaelis-Menten constant value for renin. 18 Thus, when renin is suppressed, such as when Na ϩ intake is high or K ϩ intake low, the velocity of the reaction that transforms angiotensinogen to angiotensin I by renin may increase. Alternatively, despite marked suppression of renin release on high Na ϩ diets in salt-sensitive groups, through an enhanced adrenal response to angiotensin II, 1,2,4 an attenuated decrease in aldosterone production may occur, [1] [2] [3] [4] and this may contribute to dietary salt-related increases in BP. [15] [16] [17] Although we show that circulating aldosterone concentrations are associated with a strong interaction between circulating angiotensinogen concentrations and urinary Na ϩ /K ϩ , whether aldosterone effects explain the relationship between angiotensinogen concentrations and BP in the presence of a urinary Na ϩ /K ϩ higher than the median requires further study. In this regard, it is also possible that, independent of aldosterone, renal angiotensinogen expression may have a marked effect on BP, presumably by influencing salt excretion through the actions of angiotensin II. 34 However, previous studies suggest that aldosterone does indeed play an important role in BP in groups of African ancestry. 16 Moreover, we have reported previously on an ability of the aldosterone:renin ratio, used as an index of excessive aldosterone production with respect to renin concentrations, to modify the impact of salt intake on BP in the community of African descent presently studied. 17 In the present study we also sought to identify the factors independently related to angiotensinogen. In this regard, the independent relationship between the A3 C transition at nucleotide Ϫ20 of the AGT gene and circulating angiotensinogen concentrations is in support of studies demonstrating an important role of this gene variant in angiotensinogen expression. 35, 36 Nevertheless, this relationship was insufficiently robust to translate into a relationship between AGT genotype and either circulating aldosterone concentrations or BP. The lack of relationship between the G3 A substitution at position Ϫ217 of the AGT gene and either circulating angiotensinogen concentrations or BP does not support previous observations of an important role of this gene variant in contributing toward circulating angiotensinogen concentrations or BP control. 35, 37 Because this variant modifies the impact of glucocorticoids on angiotensinogen expression, 38 a lack of association with circulating angiotensinogen concentrations may be attributed to a less important role of glucocorticoids in angiotensinogen expression and BP in the present study sample, a hypothesis that has yet to be explored. Although the present study is the first to show a relationship between CRP and circulating angiotensinogen concentrations, this relationship is likely to be accounted for by the well-recognized association that exists between inflammatory changes and angiotensinogen. 39 Furthermore, this relationship failed to translate into independent relationships with either circulating aldosterone concentrations or BP.
The limitations of the present study are as follows. The present study was a cross-sectional study, and, hence, conclusions regarding cause and effect cannot be drawn. Second, a high proportion of participants were women and obese, and we were not statistically powered to perform sex-specific analysis or analysis in categories of obesity in high compared with low Na ϩ diets. In addition, only participants of black African descent were assessed. Thus, the relationships noted may relate specifically to groups of black African ancestry, women, or obese individuals only. Third, although assessing relationships between AGT genotype and angiotensinogen or aldosterone concentrations and BP was not a primary goal of the present study, haplotype analysis of single nucleotide polymorphisms across the AGT gene was not conducted. Nevertheless, we did assess the role of AGT variants that are thought to produce the greatest impact of AGT gene haplotypes on angiotensinogen expression. 35 
Perspectives
In the present study we provide evidence to show that, in the presence of a high Na ϩ /low K ϩ diet, which suppresses renin release, circulating angiotensinogen concentrations are more closely related to aldosterone and BP than in participants receiving a low Na ϩ /high K ϩ diet. These data may explain why RAAS blockers produce a synergistic effect on BP when used in conjunction with strategies that enhance Na ϩ excretion and suggest that a combination of these strategies may be the most appropriate method of treating salt-sensitive hypertension. This is particularly important considering that only 4.3% of participants were receiving angiotensin-converting enzyme inihibitor diuretic combinations and that left ventricular hypertrophy is more prevalent in salt-sensitive groups, such as those of African ancestry, 12 where considerable benefits may accrue from RAAS blockers. 40 Table 3 except for antihypertensive treatment where appropriate. Figure S1 . Distribution of plasma renin, serum aldosterone and plasma angiotensinogen concentrations in the community sampled.
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